bioAffinity Technologies, Inc. (BIAF) NASDAQ

0.35

+0.0804(+29.78%)

Updated at September 15 04:00PM

Currency In USD

Valuation

Market Cap11.04M
Enterprise Value11.43M
P/E Ratio-0.72
PEG Ratio-0.26
Price/Sales Ratio1.31
Price/Book Ratio-3.94
Enterprise/Revenue1.29
Enterprise/EBITDA-0.9

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1.52
Operating Margin-1.31

Management Effectiveness

Return On Assets-2.46
Return On Equity-9.3

Income Statement

Revenue9.36M
Revenue/Share0.32
Gross Profit3.38M
EBITDA-8.33M
Net Income-9.04M
Diluted EPS-0.75

Balance Sheet

Total Cash802,835
Total Cash/Share0.03
Total Debt669,997
Total Debt/Equity-0.31
Current Ratio0.64
Book Value Per Share-0.09

Price History

52-Week Change-79.75
52-Week High2.26
52-Week Low0.16
Moving Average 50 Days0.29
Moving Average 200 Days0.51

Statistics

Average Volume4.8M
Shares Outstanding28.67M
% Held by Institutions2.23

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A